Bipolar pharmacotherapy and suicidal behavior. Part 3: Impact of antipsychotics

Journal of Affective Disorders

Volumn 103, Issue 1-3, 2007, Pages 23-28

  Yerevanian, Boghos I ^a,b   Koek, Ralph J ^a,b   Mintz, Jim ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Antipsychotic drugs; Bipolar disorder; Longitudinal study; Public health; Suicide; Suicide attempt

Indexed keywords

CARBAMAZEPINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BIPOLAR DISORDER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; PRIORITY JOURNAL; RISK ASSESSMENT; SUICIDAL BEHAVIOR; VETERAN;

ANTICONVULSANTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SUICIDE; SUICIDE, ATTEMPTED; VALPROIC ACID; VETERANS;

EID: 34548852844     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.05.018     Document Type: Article

References (24)

1. Agresti A. Categorical Data Analysis (1990), John Wiley & Sons, New York, NY 189-196
2. Angst J., Angst F., Gerber-Werder R., and Gamma A. Suicide in 406 mood-disorder patients with and without long-term medication: a 42-44 years' follow up. Arch. Suicide Res. 9 (2005) 279-300
3. Barak Y.I., Mirecki I., Knobler H.Y., Natan Z., and Aizenberg D. Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period. Psychopharmacology (Berl) 175 (2004) 215-219
4. Bhatia T., Thomas P., Semwal P., Thelma B.K., Nimgaonkar V.L., and Deshpande S.N. Differing correlates for suicide attempts among patients with schizophrenia or schizoaffective disorder in India and USA. Schizophr. Res. 86 (2006) 208-214
5. Brotman M.A., Fergus E.L., Post R.M., and Leverich G.S. High exposure to neuroleptics in bipolar patients: a retrospective review. J. Clin. Psychiatry 61 (2000) 68-72
6. Calabrese J.R., Keck Jr. P.E., Macfadden W., Minkwitz M., Ketter T.A., Weisler R.H., Cutler A.J., McCoy R., Wilson E., and Mullen J. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am. J. Psychiatry. 162 (2005) 1351-1360
7. Chengappa K.N., Suppes T., and Berk M. Treatment of bipolar mania with atypical antipsychotics. Expert Rev. Neurotherap. 4 6 Suppl 2 (2004) S17-S25
8. Ehret M.J., and Levin G.M. Long-term use of atypical antipsychotics in bipolar disorder. Pharmacotherapy 26 (2006) 1134-1147
9. Goldberg J.F., Allen M.H., Miklowitz D.A., Bowden C.L., Endick C.J., Chessick C.A., Wisniewski S.R., Miyahara S., Sagduyu K., Thase M.E., Calabrese J.R., and Sachs G.S. Suicidal ideation and pharmacotherapy among STEP-BD patients. Psychiatr. Serv. 56 (2005) 1534-1540
10. Hawton K., Sutton L., Haw C., Sinclair J., and Harriss L. Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors. J. Clin. Psychiatry 66 (2005) 693-704
11. Hennen J., and Baldessarini R.J. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr. Res. 73 (2005) 139-145
12. Holzer L., and Eap C.B. Aripiprazole and suicidality. Int. Clin. Psychopharmacol. 21 (2006) 125-126
13. Houston J.P., Ahl J., Meyers A.L., Kaiser C.J., Tohen M., and Baldessarini R.J. Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex. J. Clin. Psychiatry 67 (2006) 1246-1252
14. Kaneda Y. Suicidality in schizophrenia as a separate symptom domain that may be independent of depression or psychosis. Schizophr. Res. 81 (2006) 113-114
15. Keck Jr. P.E. Bipolar depression: a new role for atypical antipsychotics? Bipolar Disord. 7 Suppl 4 (2005) 34-40
16. Meltzer H.Y., Alphs L., Green A.I., Altamura C., Anand R., Bertoldi A., Bourgeois M., Chouinard G., Islam M.Z., Kane J., Krishnan R., Lindenmayer J.P., and Potkin S. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch. Gen. Psychiatry 60 (2003) 82-91
17. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
18. Nardi A.E., Nascimento I., Friere R.C., de-Melo-Neto V.L., Valenca A.M., Dib M., Soares-Filho G.L., Veras A.B., Mezzasalma M.A., Lopez F.L., de Menezes G.B., Grivet L.O., and Versiani M. Demographic and clinical features of schizoaffective (schizobipolar) disorder-a 5 year retrospective study. Support for a bipolar spectrum disorder. J. Affect. Disord 89 (2005) 201-206
19. Perlis R.H. The role of pharmacologic treatment guidelines for bipolar disorder. J. Clin. Psychiatry 66 Suppl 3 (2005) 27-47
20. Potkin S.G., Alphs L., Hsu C., Krishnan K.R., Anand R., Young F.K., Meltzer H., and Green A. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biol. Psychiatry 54 (2003) 444-452
21. Sajatovic M., Valenstein M., Blow F.C., Ganoczy D., Ignacio R.V., Scholten M.R., and Selten J.P. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 8 (2006) 232-241
22. Scholten M.R., and Selten J.P. Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug. Ned. Tijdschr. Geneeskd. 149 (2005) 2296-2298
23. Tohen M., Vieta E., Calabrese J., Ketter T.A., Sachs G., Bowden C., Mitchell P.B., Centorrino F., Risser R., Baker R.W., Evans A.R., Beymer K., Dube S., and Tollefson G.D. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch. Gen. Psychiatry 60 (2003) 1079-1088 Erratum in: Arch. Gen. Psychiatry 2004, 61, 176
24. Yerevanian B.I., et al. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine. Geoderma 103 (2007) 5-11 10.1016/j.jad.2007.05.019 (this issue)